Email Newsletters

MetroWest

🔒WBJ names the 2024 Best of Business award winners

WBJ readers voted for the top 55 companies in categories like Best Bank, Best Nonprofit Fundraiser Event, Best After-Work Bar, and Best Forensic Accountant.

🔒No path toward goal: Two years before soccer fever grips America again, Central Mass. appears to be missing out

Since 2018, professional men’s or women’s soccer teams have been announced or launched in Boston, Hartford, Pawtucket, and Portland, while New England’s second-largest city has been sitting on the proverbial sidelines.

Acton among Mass. municipalities to participate in clean energy infrastructure initiative

The Department of Energy Resources gave seven communities the final green light to begin a groundbreaking experiment: they will require new construction and major renovation to embrace fossil fuel-free infrastructure for uses like heating and cooling.

CFO of Natick-based machine vision firm to depart

Cognex has announced Paul Todgham, its senior vice president of finance and chief financial officer, will depart the company in March.
ADVERTISEMENT

Following expansion, Holliston biomanufacturer receives milestone compliance

Oligo Factory, a Holliston biomanufacturer, has become compliant with Good Manufacturing Practices, nine months after the company added 13,000 square feet to increase its manufacturing capacity.

Southborough IT firm collaborates with Amazon to open generative AI labs

Virtusa has signed a multi-year collaboration agreement with Seattle-based Amazon Web Services to allow Virtusa to open four artificial intelligence and data labs. 

Acton-based drug testing company moving headquarters to Texas after turbulent 2023

After hinting at a corporate restructuring in November, Psychemedics, an Acton-based manufacturer of hair drug testing kits, has announced it is moving their corporate headquarters to Dallas, Texas.

Allurion hires commercialization executive, expands partnership with German firm

Natick weight-loss firm Allurion Technologies has hired Brian Conyer to lead commercialization of its digital assets, including its newly launched commercial agreement with a German weight-loss group. 
ADVERTISEMENT

Boston Scientific to study irregular heartbeat treatment in new clinical trial

Marlborough medical technology firm Boston Scientific has initiated a new clinical trial to study a treatment of persistent atrial fibrillation, an irregular rapid heart rhythm.

Acton medical device firm to launch clinical trial studying sepsis system

Bluejay Diagnostics in Acton is launching a clinical trial to study the efficacy of its Symphony System in patients with sepsis, a life-threatening complication from infection.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA